Home/Filings/4/0001209191-20-063657
4//SEC Filing

SCHULZE GAIL 4

Accession 0001209191-20-063657

CIK 0001020214other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 8:51 PM ET

Size

11.2 KB

Accession

0001209191-20-063657

Insider Transaction Report

Form 4
Period: 2020-12-14
SCHULZE GAIL
Director
Transactions
  • Sale

    Common Stock

    2020-12-14$7.48/sh15,000$112,12847,393 total
  • Sale

    Common Stock

    2020-12-14$7.27/sh47,393$344,6890 total
  • Exercise/Conversion

    Option (Right to Buy)

    2020-12-1415,0000 total
    Exercise: $2.48Exp: 2021-01-02Common Stock (15,000 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-14$2.48/sh+15,000$37,20062,393 total
Footnotes (4)
  • [F1]The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.28 to $7.595 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  • [F2]The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.25 to $7.325 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  • [F3]The option became exercisable in 12 equal monthly installments after the grant date.
  • [F4]Not applicable.

Issuer

CERUS CORP

CIK 0001020214

Entity typeother

Related Parties

1
  • filerCIK 0001023259

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:51 PM ET
Size
11.2 KB